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Background: The development of resistance to conventional anti-typhoid drugs and the recent emergence of
fluoroquinolone resistance have made it very difficult and expensive to treat typhoid fever. As the therapeutic
strategies become even more limited, it is imperative to investigate non-conventional modalities. In this context,
honey is a potential candidate for combating antimicrobial resistance because it contains a broad repertoire of
antibacterial compounds which act synergistically at multiple sites, thus making it less likely that the bacteria will
become resistant. The in vitro antibacterial activity of 100 unifloral honey samples against a blood culture isolate of
multi-drug resistant (MDR) Salmonella typhi were investigated.
Methods: All honey samples were evaluated for both total (acidity, osmolarity, hydrogen peroxide and non-peroxide
activity) and plant derived non-peroxide antibacterial activity by agar well diffusion assay at 50% and 25% dilution in
sterile distilled water and 25% in catalase solution. Manuka (Unique Manuka Factor-21) honey was used for comparison.
The phenol equivalence of each honey sample from 2% to 7% (w/v) phenol was obtained from regression analysis.
The antibacterial potential of each honey sample was expressed as its equivalent phenol concentration. The honey
samples which showed antibacterial activity equivalent to or greater than manuka honey were considered
therapeutically active honeys.
Results: Nineteen honey samples (19%) displayed higher hydrogen peroxide related antibacterial activity (16–20%
phenol), which is more than that of manuka honey (21-UMF). A total of 30% of the honey samples demonstrated
antibacterial activity between 11 and 15% phenol similar to that of manuka honey while 51% of the honey samples did
not exhibit any zone of inhibition against MDR-S. typhi at 50% (w/v) dilution. None of the indigenous honey samples
displayed non-peroxide antibacterial activity. Only manuka honey showed non-peroxide antibacterial activity at 25%
dilution (w/v) in catalase solution.
Conclusions: The honey samples which displayed antibacterial activity equal to or greater than manuka honey may be
useful in the clinical conditions where higher hydrogen peroxide related antibacterial activity is required. Manuka honey,
which is known to possess non-peroxide antibacterial activity, warrants further evaluation in a suitable typhoid animal
model.
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Typhoid fever remains an important health problem in
the developing world and is a leading cause of fever in
returning travelers [1]. Resistance to the conventional
anti-typhoid antibiotics ampicillin, cotrimoxazole and
chloramphenicol is common in Asia, including in Pakistan
[2]. However, recent emergence of fluoroquinolone resist-
ance in typhoidal salmonellae has further complicated the
situation [3]. Resistance to cephalosporins like ceftriaxone
has almost exhausted the stock of useful anti-typhoid
drugs and there is obvious concern that we may be entering
a pre-antibiotic era where typhoid fever becomes untreat-
able [4]. Moreover, the recent emergence of extended-
spectrum ß-lactamases (ESBLs) in S. typhi limits the
therapeutic options to tigecycline and carbapenems as the
last resort [5]. Consequently, efforts are needed to evaluate
and develop new agents to combat this ongoing health
crisis.
Development of an antibiotic based on a single com-
pound strategy is not effective because of widespread
antimicrobial resistance and adverse drug reactions [6].
Therefore, there is an urgent need to explore those anti-
bacterial compounds which are less prone to initiate the
development of bacterial resistance and are free from
side effects. In this context, honey is a potential candi-
date for combating antimicrobial resistance because it
contains a repertoire of antibacterial compounds which
act synergistically at multiple sites, thus minimizing the
opportunity for the bacterium to become resistant [7-10].
To date, antibacterial resistance against honey has not
been documented.
Moreover, honey blocks quorum sensing [11] and dis-
rupts the formation of biofilms [12-14]. Unlike conven-
tional antibiotics, honey does not disturb the growth of
gastric beneficial bacteria, but instead it promotes the
growth of bifidobacteria and lactobacilli [15,16]. A variety
of prebiotics have also been identified in honey [17]. More
recently, a study revealed that honey can prevent the for-
mation of free radicals in an inflammatory colitis model
and application of intra-rectal honey is as effective as
prednisolone [18]. These peculiar characteristics of honey
make it a potential candidate for treatment of drug-
resistant bacterial infections, particularly in those involv-
ing the gastrointestinal tract. Most early studies focused
on the antibacterial activities of honey against bacteria
which are implicated in skin infections and therefore,
honey has been approved as a drug for the treatment of
skin infections and burns [19]. Previously, we evaluated
the antibacterial activities of two indigenous honeys, black
seed and shain honey, against multi-drug resistant ty-
phoidal salmonellae [20]. Although Pakistanis a key pro-
ducer of several varieties of honey, most have not been
screened for their antibacterial activities. Therefore,100
samples of Pakistani unifloral honey from 19 commonspecies specific floral types were collected from different
geographical areas of Pakistan and were screened for both
total and residual antibacterial activity against a clinical




A blood culture isolate of MDR-S. typhi was obtained from
the Institute of Microbiology, Military Hospital, Rawalpindi,
Pakistan. Biochemical identification of Salmonella typhi
was reconfirmed by an API-20E (bioMerieux, Inc. France)
test kit and serological identification was performed by
Salmonella O, H and Vi antisera (BD Difco, USA). The
isolate was preserved in Microbank vials (Pro-Lab Diagnos-
tics, UK) at −80°C. Before use, the strain was sub-cultured
on sheep blood agar and its characteristic features were
confirmed.
Honey samples
A total of 100 honey samples of 19 different botanical
origins (flora) from different geographical locations of
Pakistan were collected and investigated for antibacterial
potential against MDRS. typhi (UHS-16) (Table 1). These
samples were obtained from commercial apiarists (n = 90),
Honey Bee Research Farm, Punjab University (PU), Lahore
(n = 4) and Honey Bee Research Farm, National Agricul-
tural Research Council (NARC), Islamabad (n = 6) from
April 2006 to December 2009. Honey samples were col-
lected from 21 districts of Pakistan (Table 2). Identification
of the plant source of the honey samples were performed
on the basis of the geographical location, flowering plants,
season, aroma and color of each honey [21,22]. The honey
samples were placed in the dark at room temperature
(20–30°C).
Screening of honey
Agar well diffusion assay
All honey samples were screened by agar well diffusion
assay as adopted from the work of Allen et al., (1991)
with slight modifications [21]. Agar well diffusion is the
most frequently used assay for determining the antibac-
terial activity of honey because of its simplicity and low
cost [22-24]. Manuka honey (UMF- 21) was used for
comparison. Manuka honey has an antibacterial activity
equivalent to 21% phenol (w/v), as previously determined
against a reference strain of Staphylococcus aureus (ATCC
25923) [21] and was kindly provided by Professor Peter
C. Molan, Department of Biological Sciences (Honey
Research Unit), University of Waikato, New Zealand.
Cefixime (5 μg) disc and ciprofloxacin (5 μg) disc, (Oxoid,
Basingstoke, UK) were used as positive controls. These
antibiotics gave a zone of inhibition which was used to
account for day to day variations. Sterile distilled water
Table 1 Details of Pakistani unifloral honeys screened for antibacterial activity (n = 100) against MDR-Salmonella typhi
(UHS = 16)
Serial no Common name Botanical name Code no No. of samples
1 Acacia/Phulai Acacia modesta AC 15
2 Beri Ziziphus jujuba BE 29
3 Bhaiker Justicia adhatoda BK 05
4 Black locust Robinia pseudoacacia RPA 03
5 Black seed Nigella sativa BS 05
6 Clover/Shatala Trifolium alexandrium CL 04
7 Date palm Phoenix dactylifera DT 01
8 Eucalyptus Eucalyptus spp. EU 01
9 Garanda Carissa opaca GN 04
10 Honey dew Honey dew HD 01
11 Lavender Lavendula intermedia LAV 01
12 Litchi Litchi chinesis LY 02
13 Loquat Eriobotrya japonica LO 01
14 Mustard Brassica spp. MH 04
15 Orange blossom Citrus sinensis CT 12
16 Russian olive Elaeagnus angustifolia RO 05
17 Shain Plectranthus rugosus wall SH 01
18 Sunflower Helianthus annus SN 05
19 Walati kikhar Prosopis spp. WK 01
Table 2 District (n = 21) wise distribution of Pakistani
unifloral honey used in this study
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with catalase solution can neutralize the hydrogen perox-
ide related antibacterial activity in honey, those honey
samples which retained antibacterial activity after addition
of catalase solution are considered to have plant derived
non-peroxide activity [21,22].
MDR-S. typhi was sub-cultured onto sheep blood agar
plates and incubated for 24 hours at 37°C. Morphologic-
ally identical colonies were picked and suspended in
sterile 10 ml tryptic soya broth (TSB) and incubated for
approximately 5 hours at 37°C to attain a fully logarithmic
phase culture. The culture was adjusted to 0.5 McFarland
turbidity calculated at 540 nm using sterile TSB as a blank
and a diluent with a 1 cm pathway.
To prepare the large square Bio-Assay plates (low pro-
file, sterile polystyrene, 649560–241 × 241 × 20 mm,
Nalge Nunc International, USA), 150 ml Mueller Hinton
(MH) agar (Oxoid Ltd, UK) was autoclaved and kept at
50°C for 30–35 minutes prior to seeding with 100 μl of
S. typhi culture adjusted to 0.5 McFarland turbidity. The
agar was mixed thoroughly by swirling and poured into
a Bio-Assay plate and maintained at 4°C overnight. The
next day, 47 wells were made in the agar with a sterile
9 mm cork borer using a quasi-Latin square as a tem-
plate. The template was constructed on a black card
(241 × 241 mm), and a 30 mm grid was drawn on the
card. The wells were centered at each of the 47
Table 3 Zone of inhibition (mm) of phenol in triplicate
against MDR-Salmonella typhi (UHS-16) by the agar well
diffusion assay
Phenol concentration (w/v) Mean zone size Mean squared
2% 0 0
3% 11.95 ± 0.08 142.80
4% 16.04 ± 0.02 257.28
5% 20.94 ± 0.07 438.48
6% 23.80 ± 0.74 566.44
7% 26.26 ± 0.28 689.58
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numbered using a quasi-Latin square. This allows the
samples to be placed randomly on the plate. On two
intersections, wells were not made and used for the
positive controls, cefixime (5 μg) and ciprofloxacin (5 μg).
Sample preparation
Initially a primary solution (50% w/v) from each honey
sample was prepared by adding 2 g of well-mixed honey
to 2 ml of sterile distilled water (SDW) in universal
bottles. They were incubated at 37°C for 30 minutes to
aid dissolution by intermittent stirring. Secondary honey
solutions (25% w/v) were prepared by taking 1 ml of
honey from each primary solution and mixing with 1 ml
of SDW or 1 ml catalase solution. The catalase solution
was prepared by adding 20 mg catalase (bovine liver,
Sigma C1345-10G 2950 units/mg) to 10 ml of SDW.
The dilutions of honey were made based on the results
of two previous antibacterial screening studies [21,22].
To determine the phenol equivalence of each honey
sample, 2% to 7% (w/v) phenol (crystallized, extra pure,
Scharlau, FE0480, Spain) solutions were prepared and
used as standards [25,26].
Each honey sample and controls were tested in tripli-
cate by adding 140 μl to each well. Sterile distilled water,
catalase solution, cefixime (5 μg) and ciprofloxacin
(5 μg) were used as controls. The plates were incubated
for 18 hours at 37°C after applications of samples and
controls. The clear zones produced by each sample
and control were measured in mm with digital calipers
(Sylvac, Fowler, Ultra-Call11).
Statistical analysis
For each experiment, three replicates were performed.
The data were analyzed by using SPSS 15.0 after check-
ing the assumption of normality. The arithmetic mean
of observations and standard deviation of mean values
were calculated. Statistical significance of the difference
in the zone of inhibition among the different honey
samples was determined with one way ANOVA (analysis
of variance), and if found to be significant, a post hoc
Tukey’s test was applied to evaluate the differences in
the zone of inhibition between the honey samples. For
all statistical tests, results were considered to be signifi-
cant at p ≤ 0.05.
A standard reference curve was plotted for the %
phenol solutions against the square mean diameter of
the inhibition zone around each phenol concentration
obtained from the agar well diffusion assay. The linear
line of best fit was drawn and a regression equation gen-
erated using the Statistical Package for Social Sciences
(SPSS 15.0). The phenol equivalence for each honey
sample was calculated from the square mean diameter
of the inhibition zone. The result was multiplied by afactor of 4.69 to account for the dilution and density of
the honey assuming that the honey had a mean density
of 1.35 mg/ml [21]. The antibacterial potential of each
honey was then expressed as an equivalent phenol
concentration (% w/v). Those honey samples which showed
antibacterial activity equivalent to or greater than manuka
honey were considered therapeutically active honeys.
Results
Phenol equivalence of honey samples
None of the indigenous honey samples produced a zone
of inhibition against MDR-S. typhi at 25% (w/v) dilution
in sterile distilled water or in the presence of catalase
solution. By comparison, manuka honey displayed a
12 mm inhibition zone at both 25% (w/v) dilution in
sterile distilled water and in the presence of catalase.
However, some indigenous honey samples showed a zone
of inhibition at 50% (w/v) dilution in sterile distilled water
and thus, their phenol equivalences were calculated
(Table 3). The inhibition zones produced by different dilu-
tions of phenol against MDR-S. typhi are shown in Table 3.
Phenol at 2% (w/v) did not produce any zone of inhibition
against MDR-S. typhi. However, the other phenol dilutions
did exhibit a zone of inhibition. The inhibition zone tends
to increase with increasing phenol concentration (Table 3).
The calibration curve for the different phenol dilutions
and the regression equation (y = 2.016 + .007 (x)) obtained
are presented in Figure 1. The adjusted R square for
the phenol standard curve was 0.996. The relationship
between the phenol solutions and the zone of inhibition
is linear over the entire range tested. Phenol equiva-
lence was calculated for each indigenous honey sample
from the phenol standard curve. Table 4 shows the
antibacterial activity of each honey sample expressed in
phenol equivalence (%w/v). The range of antibacterial
activity of all indigenous honey samples tested in this
study in terms of their phenol equivalences against MDR-S.
typhi was obtained between 0 and 20%. This range was
further divided into four groups: 0–5%, 6–10%, 11–15%,
and 16–20%. The phenol equivalence obtained for manuka
honey against MDR-S. typhi was 13%, thus classifying it as
having significant activity (11–15%).
























Ad.R Sq Linear = 0.996
y = 2.016 + .007 (x) 
Figure 1 Calibration curve for the phenol solutions used in the agar-well-diffusion assay of antibacterial potential against MDR-Salmonella
typhi (UHS-16).
Table 4 Phenol equivalence of Pakistani honeys at 50%
(w/v) dilution against MDR-Salmonella typhi expressed in
Inhibine Antibacterial Units (IBU)
Honey
samples (n)
Phenol equivalence % (w/v)/ IBU
0–5 6–10 11–15 16–20
Manuka (Standard) 0 0 1 0
Acacia (15) 10 0 3 2
Beri (29) 7 0 12 10
Bhaiker (5) 4 0 1 0
Black locust (3) 3 0 0 0
Black seed (5) 1 0 4 0
Citrus (12) 11 0 1 0
Clover (4) 2 0 1 1
Date palm (1) 0 0 1 0
Eucalyptus (1) 0 0 0 1
Garanda (4) 0 0 3 1
Honey dew (1) 0 0 0 1
Lavender (1) 1 0 0 0
Litchi (2) 2 0 0 0
Loquat (1) 1 0 0 0
Mustard (4) 3 0 1 0
Russian olive (5) 4 0 1 0
Shain (1) 0 0 0 1
Sun flower (5) 2 0 2 1
Walati kikher (1) 0 0 0 1
Total 51 0 30 19
Key: 0–5, insignificant activity; 6–10, low activity; 11–15, significant activity;
16–20, high activity.
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samples
A total of 51% of honey samples had phenol equivalence
between 0 and 5% (insignificant activity group) against
MDR-S. typhi at 50% (w/v) dilution in SDW (Table 4).
A total of 30% of the honey samples demonstrated anti-
bacterial activity between the ranges of 11–15% phenol
(significant activity group), similar to that of manuka
honey (Table 4). Out of the four tested, three garanda
honey samples displayed antibacterial activity between
the ranges of 11–15%, similar to that of manuka honey.
One garanda honey sample showed antibacterial activity
between 16 and 20% (high activity group), higher than that
of manuka honey. A total of 12 beri honey samples
displayed significant antibacterial activity (11–15% of
phenol), similar to that of manuka honey. Moreover,
ten beri honey samples displayed antibacterial activity
greater than that of manuka honey. Out of five black
seed honey samples, four were in the significant group
(11–15% of phenol), similar to that of manuka honey
(Table 4). Overall, 19 honey samples displayed higher
antibacterial activity (16–20% of phenol) than that of
manuka honey, including beri (n = 10), acacia (n = 2), clo-
ver (n = 1), eucalyptus (n = 1), garanda (n = 1), sunflower
(n = 1), honey dew (n = 1), walati kikher (n = 1) and shain
(n = 1) (Table 4).
Mean and standard deviation of the antibacterial activity
of different honey varieties
Mean and standard deviation of the antibacterial activity
of the honey groups comprising more than one sample
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the highest antibacterial activity (15.25 ± 0.50), fol-
lowed by beri honey (11.76 ± 6.8) and black seed honey
(11.60 ± 6.5). Robinia and litchi honey did not show any
activity in this study. One way analysis of variance
(ANOVA) found a significant difference (p = 0.0001) in
the size of the inhibition zone among the different
honey groups demonstrating the variation in the potency
of antibacterial activity among different honey groups.
Discussion
Hydrogen per-oxide related antibacterial activity
Out of 100 honey samples, 19% displayed higher anti-
bacterial activity (16–20% of phenol) at 50% dilution
compared with that of manuka (Table 4). These included
beri, acacia, clover, eucalyptus, garanda, sunflower, honey
dew, walati kikher and shain honey (Table 4). However,
garanda honey, beri honey and black seed honey showed
higher mean antibacterial activity (Table 5). This indi-
cated the occurrence of a high level of hydrogen perox-
ide related antibacterial activity in these indigenous
honey samples. Previously, buckwheat honey, ulmo
honey and jarrah honey were found to contain high
levels of hydrogen peroxide activity [25,27,28]. Hydrogen
peroxide, present in most honey at variable concentra-
tions, is generally considered to be the main contributor
to the antibacterial activity of honey [27,29]. However,
the concentration of H2O2 in honey is approximately
400–4000 times lower than that required for bacterioly-
sis [9] and hydrogen peroxide alone is less bacteriostatic
than the equivalent amount present in honey [30]. It hasTable 5 Mean and standard deviation of the antibacterial
activity of different honey groups according to floral
source (expressed as phenol equivalence % (w/v) against
MDR-Salmonella typhi (UHS-16) and 90% Confidence
Intervals for the means
Honey
samples (n)
Mean ± SD 95% CI* for mean
Lower limit Upper limit
Beri (29) 11.76 ± 6.8 9.16 14.36
Acacia (15) 05.13 ± 7.5 0.94 9.33
Citrus (12) 01.25 ± 4.3 −1.50 4.00
Black seed (5) 11.60 ± 6.5 3.52 19.68
Bhaiker (5) 02.80 ± 6.2 −4.97 10.57
Sunflower (5) 09.00 ± 8.2 −1.24 19.24
Russian olive (5) 02.80 ± 6.2 −4.97 10.57
Garanda (4) 15.25 ± 50 14.45 16.05
Mustard (4) 03.50 ± 7.0 −7.64 14.64
Clover (4) 07.50 ± 8.6 −6.34 21.34
Robinia (3) 0 0 0
Litchi (2) 0 0 0
*CI, confidence interval.been shown that the antibacterial activity of honey can be
augmented by polyphenols and a synergistic interaction
was identified between H2O2, polyphenols and transition
metals [31]. These findings further strengthen the notion
that hydrogen peroxide is one of main compounds
involved in the antibacterial activity of honey. Unlike
hydrogen peroxide induced cytotoxicity when tested in
isolation, honey has no tissue damaging effects because
it generates optimal levels of hydrogen peroxide to the
applied areas [32]. The antibacterial effects of •OH are
more potent as compared to H2O2 because the former
cannot be neutralized by any enzyme [33]. Recently, it
has been revealed by a 3′-(p-aminophenyl) fluorescein
(APF) •OH trap technique that the oxidative stress
induced by honey on bacterial cells is not related to
molecular H2O2 but rather the presence of the •OH
radical generated from honey H2O2. A recent study
revealed that •OH inhibited the growth of both multi-
drug resistant (MRSA and VRE) and standard bacteria
(E. coli and B. subtilis) [34]. Unlike H2O2 and methyl-
glyoxal, which are inactivated by catalase and gastric
enzymes respectively, •OH is a stable substance which
is not inactivated by any endogenous or exogenous
enzyme [33,35]. These findings open new avenues for
future research into the induction of •OH containing
honeys as a potential therapeutic agent for wound and
systemic infections. The presence of •OH produced by
honey could be a valuable marker for determination of the
antibacterial efficacy of honeys for clinical applications
[34]. Currently, the non-peroxide activity of manuka
honey is given more importance clinically than its
peroxide based activity, which is measured in term of
unique manuka factor [21]. The difference in clinical
efficacy of UMF honey like manuka and high hydrogen
peroxide containing honey like buckwheat, ulmo and
jarrah [25,27,28] to treat wound infections has not been
tested yet.
Absence of antibacterial activity of honey samples
A total of 51% of honey samples did not exhibit any
antibacterial activity against MDR-S. typhi at any dilution
(Table 4). Out of 12, only one sample of citrus honey
showed antibacterial activity. Similarly, most of the acacia,
bhaiker, Russian olive and mustard honey samples fail to
exhibit any antibacterial activity against MDR-S. typhi.
Moreover, all samples of robinia, pseudoacacia and litchi
honey were unable to produce antibacterial activity against
MDR-S. typhi. In a previous study where 340 honeys were
screened, 68.5% did not demonstrate antibacterial activity
against S. aureus (ATCC 25923) [22]. A study of 345
honey samples showed that 36% had antibacterial activity
against S. aureus (ATCC 25923) at concentrations below
the level of detection [21]. However, direct comparison of
these results to previous studies is often difficult because
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tivity of honey samples might be as a result of improper
processing or handling of honey. In Pakistan, the over-
whelming majority of people believe that any honey
that granulates is altered or synthetic. Therefore, the
majority of bee keepers and packers heat the honey in
order to prevent crystallization/granulation. However,
the majority of honeys produced in the world tend to
granulate naturally [36]. Heating adversely affects the
quality of the honey by destroying a number of valuable
enzymes, including oxidase which is responsible for the
production of hydrogen peroxide in honey [37]. There-
fore, it is important that honey should not be heated
during processing and be stored in brown glass containers
like other medical products [37]. The production of clinic-
ally valuable honeys requires the honey to be collected,
processed and stored under standard conditions. This
demands the identification of the appropriate floral sources,
and the development of procedures for harvesting and
handling [22].
Variations in the level of antibacterial activity of honey
samples
Like the previously reported preliminary studies, these
results also demonstrate that the antibacterial activity of
honey varies tremendously among different honey sam-
ples [21,38,39] (Table 4). A high level of antibacterial
activity against MDR-S. typhi was found to be associated
with garanda honey, beri honey and black seed honey.
Conversely, robinia honey, litchi honey, loquat honey,
black locust honey and lavender honey did not show any
detectable antibacterial activity in this assay (Table 4). A
profound degree of disparity in the antibacterial activity
of honey from the same floral source but from different
geographical locations was also observed in this study as
documented in other studies [21,39,40] (Table 4). For
example, beri honey showed a high degree of variation
(0–18% of phenol equivalence) among the samples col-
lected from different geographical areas of Pakistan
(Table 4). A high degree of activity was observed for beri
honey samples collected from the Karak district of
Pakistan. Generally low activity was detected in beri
samples collected from the Attock district. The difference
in antibacterial activities within the same floral source
could be related to soil composition, influence of climate,
processing of honey and concentration of propolis [41].
Previous reports also mentioned the marked degree of
variation in the antibacterial potential of 50 manuka honey
samples (16.2 ± 10.5), collected from different geograph-
ical locations of New Zealand. Non-peroxide activity was
attributed to only 38% of the samples and many did not
show any detectable activity [21]. This result also confirms
that the antibacterial activity is not associated with each
and every honey sample.Non-peroxide antibacterial activity of honey samples
None of the indigenous honey samples exhibited non-
peroxide activity, whereas manuka honey (UMF-21)
showed non-peroxide activity against MDR-S. typhi. The
absence of non-peroxide based antibacterial activity of
the indigenous honey samples could be attributed to the
lack of sensitivity of the agar well diffusion assay. The
indigenous honey samples may contain large antibacter-
ial compounds which may not diffuse out from the well
and thus be unable to produce a zone of inhibition. For
instance, Polymyxin, a large compound, is unable to diffuse
in a disk diffusion test, hence MIC type assays, like the agar
dilution assay or broth dilution assay are recommended for
determining its efficacy [42]. Therefore a more sensitive
assay may be necessary for determining the antibacterial
activity of honey. However, manuka honey displayed a
12 mm inhibition zone against MDR-S. typhi after the
addition of catalase solution at 25% dilution. Generally
these results are in agreement with previous reports,
however, previous studies evaluated manuka honey against
Staphylococcus aureus (ATCC 25923) and showed that it
exhibited an inhibition zone of 14 mm against Staphylo-
coccus aureus (ATCC 25923) [21,22]. The difference in
the size of the inhibition zone is most likely because of
the difference in test organisms. It has been shown in
previous studies that S. aureus is more sensitive to
honey than S. typhi [43].
Phenol equivalence of honey samples
The phenol equivalence of each indigenous honey sample
against MDR-S. typhi was calculated from the phenol
standard curve (Figure 1). The phenol equivalence obtained
for each honey sample is the measure of the total antibac-
terial activity (peroxide and non-peroxide) of honey against
S. typhi taking into account that the honey samples were
diluted 50% in sterile distilled water without catalase. The
total activity of the honey samples expressed in phenol
equivalence is quoted in Inhibine Antibacterial Units (IBU)
in this study. However, the phenol equivalence of each
honey sample in terms of its non-peroxide activity was not
determined because none of the indigenous honey samples
showed antibacterial activity in catalase solution. The inhi-
bine consists of hydrogen peroxide, flavonoids, phenolic
acids and several other unidentified substances present in
honey [43]. Thus, the word inhibine represents the total
antibacterial activity of honey, and therefore IBU represents
a measure of the total antibacterial activity of honey sam-
ples expressed in phenol equivalence. IBUs were grouped
into four ranges: 0–5, 6–10, 11–15 and 16–20 (Table 4).
The manuka honey used in this study is a standardized
product with 21 UMF and approved by the FDA as thera-
peutic agent for wound care [44]. Therefore, those honey
samples which displayed antibacterial activity greater than
manuka honey may be useful in the clinical conditions
Hussain et al. BMC Complementary and Alternative Medicine  (2015) 15:32 Page 8 of 9where a higher level of hydrogen peroxide related antibac-
terial activity is required.
Potential delivery methods of honey for salmonella typhi
infection
One important issue to consider when using honey to
treat typhoid fever is how to achieve a honey concentra-
tion in target organs like spleen, liver, lymphoid tissue of
the small intestine and blood at sufficient concentrations
to be both active and bactericidal for multi-drug resist-
ant S. typhi. To achieve the necessary concentrations for
treatment of S. typhi, honey could be delivered orally or
intravenously. Honey has been used as a food since an-
tiquity, present almost everywhere and can be given
safely by the oral route. However, the disadvantage of
the oral route would be the dilution of honey by large
amounts of body fluid e.g. saliva, gastric juice, intestinal
fluid and water from food and drink [45]. Therefore, it is
uncertain how much honey would be able to reach the
blood, spleen, liver and other locations where S. typhi
may colonize. Second, H2O2 activity could be neutral-
ized by catalase present in tissues and blood. Hence,
non-H2O2 containing honey like manuka, which con-
tains methylglyoxal, may be more suited to treat typhoid
fever. However, it has been shown that methylglyoxal
present in manuka honey is readily digested and inacti-
vated in the gastrointestinal tract thus the concentration
of honey achievable at site of infection would be much
lower than the concentration required to be bactericidal
against S. typhi [35]. Therefore, use of the oral route of
honey delivery for eradication of S. typhi might not be
useful. Nevertheless, it is worth mentioning that recently
it has been revealed that polyphenols present in honey
generate •OH from H2O2 via Fenton activity in the pres-
ence of Cu(I) or Fe(II) and the antibacterial effects of
•OH are more potent compared with H2O2 because the
former cannot be neutralized by any enzyme [34].
Therefore, the honeys which contain higher amounts of
polyphenols and hydrogen peroxide like buckwheat
honey may produce more •OH and thus, be more effect-
ive in vivo against S. typhi. More recently, it has been
shown that the stability and bioactivity of methylglyoxal
can be increased by coupling it with cyclodextrins [35].
The other possible means of honey administration is the
intravenous route which may allow a concentration of
honey greater than the MIC to be achieved in the serum
of a patient with typhoid fever. The usefulness and safety
of intravenous honey (i.v.) has been shown in healthy
sheep where slow i.v. infusion or rapid i.v. injection of
honey at different concentrations (5% and 40% in nor-
mal saline or sterile distilled water) was safe, could lower
blood sugar and improved renal, hepatic, and bone mar-
row functions and the lipid profile [46]. However, in
order to confirm the efficacy of oral or intravenoushoney against typhoid fever, pharmacodynamic studies
in mouse typhoid model are ongoing in our laboratory.
Conclusions
The results in the present study revealed that Pakistani
honeys as well as manuka honey has antibacterial activity
against MDR-Salmonella typhi. The results also demon-
strated the presence of a higher level of hydrogen peroxide
related antibacterial activity in some indigenous honey
samples (19%) against MDR-Salmonella typhi compared
with manuka (UMF-21) honey. Therefore, these honey
samples could be utilized in the clinic where higher H2O2
related antibacterial activity is required. However, only
manuka honey displayed non-peroxide antibacterial activ-
ity in this study while the indigenous honey samples did
not. Therefore, manuka honey warrants further evaluation
in a suitable typhoid animal model for evaluation of its
utility in the prevention and treatment of typhoid fever.
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